Novavax announces proposed public offering; Can scientists turn rice into vaccine storage?;

> Novavax ($NVAX) intends to offer to sell $100 million of its common stock in an underwritten public offering. Release

> Astellas has submitted a marketing application for flu vaccine ASP7374 in Japan. Release

> Oncothyreon ($ONTY) and Celldex Therapeutics ($CLDX) will collaborate on a combination immunotherapy clinical trial. Release

> The PATH Malaria Vaccine Initiative has named C. Richter King as its R&D director. More

> The United Nations Foundation and Walgreens received an award from the Cause Marketing Forum for their "Get A Shot. Give A Shot" campaign, which provided 3 million vaccines to children in developing countries. Release

> Researchers have developed a patch to help overcome needle phobia so that vaccines can be delivered pain- and stress-free. More

> Wisconsin's FluGen has raised $3.4 million for a Phase I trial of its universal flu vaccine candidate. Report

And Finally... A team of scientists at the University of Tokyo is trying to convert rice into a cheap storage and effective delivery vehicle for vaccines. More

Suggested Articles

Singapore has suspended the use of two flu vaccines, from SK Bioscience and Sanofi, amid reports of deaths in South Korea after immunization.

As of Friday after local time, 36 people have died in Korea after getting flu shots provided by at least seven companies, including Sanofi.

As COVID-19 vaccines advance, the FDA held an expert hearing Thursday to talk safety, efficacy, distribution plans and vaccine confidence—plus more.